Register
Clinical News
eMediNexus Coverage from: 
A new device for treating moderate to severe chronic heart failure in patients
eMediNexus,  22 March 2019
remove_red_eye 600 Views
#Business And Medicine #Cardiology #Internal Medicine

1 Read Comments                

The US Food and Drug Administration (FDA) has approved the Optimizer Smart system for treating patients with chronic, moderate-to-severe heart failure who are not suited for treatment with other heart failure devices such as cardiac resynchronization therapy to restore a normal timing pattern of the heartbeat. The FDA gave the device a Breakthrough Device designation because it treats a life-threatening disease, heart failure, and addresses an unmet medical need in patients who fail to get adequate benefits from standard treatments and have
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now